Kothari Industrial Corporation Ltd
Incorporated in 1970, Kothari Industrial Corporation Ltd manufactures fertilizers,
FMCG and Health Care products[1]
- Market Cap ₹ 4,642 Cr.
- Current Price ₹ 434
- High / Low ₹ 625 / 56.1
- Stock P/E
- Book Value ₹ 25.4
- Dividend Yield 0.00 %
- ROCE -13.7 %
- ROE -17.2 %
- Face Value ₹ 5.00
Pros
- Company is expected to give good quarter
- Debtor days have improved from 57.9 to 23.3 days.
Cons
- Stock is trading at 17.1 times its book value
- Company has low interest coverage ratio.
- Working capital days have increased from -287 days to 455 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Fertilizers
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79 | 52 | 48 | 34 | 16 | 18 | 18 | 12 | 9 | 10 | 14 | 87 | 140 | |
| 89 | 58 | 51 | 33 | 19 | 21 | 20 | 13 | 13 | 16 | 34 | 102 | 160 | |
| Operating Profit | -11 | -6 | -3 | 1 | -3 | -3 | -3 | -1 | -4 | -7 | -20 | -15 | -20 |
| OPM % | -13% | -12% | -6% | 3% | -17% | -14% | -15% | -9% | -38% | -70% | -146% | -18% | -14% |
| 5 | 1 | 2 | 1 | 1 | 4 | -4 | 1 | 3 | -2 | 63 | 1 | 1 | |
| Interest | 2 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 10 | 11 | 3 | 2 | 2 |
| Depreciation | 1 | 0 | 5 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4 |
| Profit before tax | -9 | -6 | -6 | -6 | -3 | 1 | -7 | -1 | -11 | -20 | 40 | -17 | -24 |
| Tax % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | 1% | -0% | 21% | -7% | |
| -9 | -6 | -6 | -6 | -3 | 1 | -7 | -1 | -11 | -20 | 32 | -16 | -24 | |
| EPS in Rs | -6.91 | -4.71 | -4.54 | -4.57 | -2.03 | 0.49 | -5.65 | -0.54 | -8.80 | -15.84 | 25.38 | -1.74 | -3.00 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 38% |
| 3 Years: | 109% |
| TTM: | 243% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -10% |
| TTM: | -157% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 663% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | -17% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 6 | 46 | 53 |
| Reserves | -2 | -12 | -21 | -27 | 2 | 4 | -4 | -4 | -37 | -57 | 2 | 134 | 219 |
| 20 | 16 | 15 | 11 | 12 | 13 | 13 | 13 | 63 | 73 | 33 | 5 | 31 | |
| 43 | 49 | 49 | 53 | 57 | 56 | 44 | 45 | 12 | 23 | 16 | 14 | 9 | |
| Total Liabilities | 67 | 59 | 53 | 47 | 81 | 82 | 63 | 64 | 46 | 48 | 57 | 200 | 312 |
| 41 | 37 | 31 | 27 | 59 | 59 | 42 | 42 | 27 | 28 | 30 | 39 | 73 | |
| CWIP | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Investments | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 99 |
| 26 | 22 | 22 | 20 | 22 | 23 | 21 | 22 | 19 | 20 | 27 | 161 | 140 | |
| Total Assets | 67 | 59 | 53 | 47 | 81 | 82 | 63 | 64 | 46 | 48 | 57 | 200 | 312 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 8 | -4 | 1 | -26 | 1 | -22 | 1 | -32 | -154 | |
| 2 | 1 | 0 | 0 | -0 | -0 | 24 | 0 | 4 | -0 | 110 | -13 | |
| -3 | -4 | -0 | -8 | 4 | -1 | 2 | -1 | 18 | -1 | -78 | 187 | |
| Net Cash Flow | -0 | -1 | 0 | -0 | -1 | -0 | -0 | -0 | -0 | 0 | 0 | 20 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 28 | 17 | 22 | 25 | 110 | 100 | 123 | 154 | 87 | 104 | 47 | 23 |
| Inventory Days | 21 | 22 | 23 | 25 | 77 | 45 | 38 | 58 | 111 | 120 | 56 | 41 |
| Days Payable | 76 | 62 | 66 | 62 | 385 | 319 | 201 | 285 | 119 | 86 | 154 | 41 |
| Cash Conversion Cycle | -27 | -23 | -21 | -11 | -198 | -174 | -41 | -74 | 79 | 137 | -51 | 23 |
| Working Capital Days | -114 | -195 | -211 | -463 | -937 | -879 | -665 | -1,029 | -66 | -432 | -883 | 455 |
| ROCE % | -27% | -33% | -82% | -15% | -9% | -9% | -4% | -11% | -20% | -20% | -14% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 17 Nov
-
Receipt Of 'In-Principle' Approval Under Regulation 28(1) Of The SEBI (LODR), Regulations, 2015 From BSE Limited For Proposed Issue Of 1711068 Equity Shares Of The Company On Preferential Basis
15 Nov - BSE granted in-principle approval for preferential issue of 1,711,068 shares at Rs.207 each.
-
Results-Standalone And Consolidated Un-Audited Financial Results For The Quarter And Half-Year Ended 30Th September 2025
14 Nov - Acquired 30% of Phoenix Kothari (29 Sep 2025) for Rs99.06 crore; auditor flagged legal, TDS Rs8.67 lakh.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 14.11.2025
14 Nov - Acquired 30% of Phoenix Kothari Footwear for Rs99.06 crore; auditor flagged TDS default Rs8.67 lakh and pending litigation
-
Board Meeting Intimation for To Consider And Approve Standalone And Consolidated Un-Audited Financial Result For The Quarter And Half Year Ended 30Th September 2025.
3 Nov - Board meeting on Nov 14, 2025 to approve Q2/H1 FY2026 unaudited results for quarter/half year ended 30 Sep 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Aug 2025TranscriptNotesPPT
Business Overview:[1][2]
The company produced Single Super Phosphate at its Ennore, Chennai unit. Production was discontinued due to a scarcity of quality raw materials and a lack of working capital. The company offered M/s. Coromandal International Ltd to operate the facilities on a lease basis, as they are in a similar business.
Currently, company has leased out its factory to M/s. Coromandel International Ltd for business arrangements and modernization of factory for 5 years; starting from FY21.